Letter by Westerink and Visseren Regarding Article, "Ezetimibe in Combination With Statins Ameliorates Endothelial Dysfunction in Coronary Arteries After Stenting : The CuVIC Trial (Effect of Cholesterol Absorption Inhibitor Usage on Target Vessel Dysfunction After Coronary Stenting), a Multicenter Randomized Controlled Trial"

DSpace/Manakin Repository

Letter by Westerink and Visseren Regarding Article, "Ezetimibe in Combination With Statins Ameliorates Endothelial Dysfunction in Coronary Arteries After Stenting : The CuVIC Trial (Effect of Cholesterol Absorption Inhibitor Usage on Target Vessel Dysfunction After Coronary Stenting), a Multicenter Randomized Controlled Trial"
 
Westerink, Jan; Visseren, Frank
(2017) Arteriosclerosis, Thrombosis and Vascular Biology, volume 37, issue 5
(Comment)
Download/Full Text
The full text of this publication is not available.
Version on publisher website for UU-students and staff
Version on publisher website
 
Keywords: Letter, Letter
DOI: https://doi.org/10.1161/ATVBAHA.117.309295
ISSN: 1079-5642
Publisher: Lippincott Williams and Wilkins
(Peer reviewed)